Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn


Morningstar runs the numbers

Lex Hall  |  16 Mar 2020Text size  Decrease  Increase  |  
Email to Friend

We take a numerical look through this week's Morningstar research. Plus, our most popular articles and videos for the week ended 13 March.

More than $15 trillion

The amount the coronavirus had wiped out in under a month as of “Black Friday” 13 March. The fast-spreading coronavirus, which the World Health Organisation termed as a pandemic, has spooked risky assets across the world. By Monday 16 March, Australia's share market has suffered its worst loss in history as the epidemic worsens, with another $182 billion in value wiped from the books. The benchmark S&P/ASX200 finished down 537.3 points, or 9.7 per cent, to 5002, eclipsing an 8.3 per cent drop back on 10 October 2008, during the height of the global financial crisis.

-0.2 per cent

That’s the forecast average negative impact on long-term global GDP from the coronavirus, says Morningstar strategist Karen Andersen. “To be sure, we expect a much larger impact in the short run (with an average negative 1.5 per cent impact on 2020 world GDP across our scenarios),” says Andersen. “However, equity valuations on average should be unscathed if our long-term projections on GDP are correct. Therefore, we think a 10 per cent plus fall in global equities since the outbreak began is a gross overreaction.”

More than 30

That’s the amount of Australian stocks now in 5-star territory, which means they're significantly undervalued by analyst measures. A week ago, there were 11. Johannes Faul, director of equity research, explains that because analysts don't see the intrinsic values of these firms as being materially impacted by the outbreak long-term, investors can buy these names at a margin of safety. Don't think of this as a list of "buys," though. Instead, think of it as a collection of names to investigate further. "A 5-star rating does not suggest that the stocks won't drop further," he says. "Our aim is not to pick the bottom, but to highlight to investors that they can pick names up at a discount."

50 per cent

And even more. That’s the discount on some Australian energy producers following the oil price shock, according to Morningstar equity analyst Mark Taylor. The standoff between OPEC and Russia has forced prices into a tailspin but fundamentals remain intact and Australian producers appeal. “At current share prices, appeal is broadly comparable with all names trading at roughly half fair value, and all in 5-star territory,” Taylor says, citing Woodside, Beach Energy, Santos and Oil Search. “Stocks are certainly cheap at this price with discounts of 50 per cent or more; it's just a question of whether you want to wait one to two years.”


That’s the number of initial public offerings over the financial year until the end of February. That’s 13 fewer than at the same time last year, says Nicki Bourlioufas. Over the financial year to 29 February 2020, the number of IPOs on the ASX stood at 69, compared to 82 the same period a year earlier. According to Marcus Ohm, Partner, Corporate and Audit Services at HLB Mann Judd, IPO activity is likely to remain subdued this year as investment in equities falls generally given very high levels of uncertainty and volatility. “I don’t expect this to change significantly in the next few months until some of those uncertainties are resolved,” says Ohm.

Most popular articles

Top videos


Investing Compass
Listen to Morningstar Australia's Investing Compass podcast
Take a deep dive into investing concepts, with practical explanations to help you invest confidently.
Investing Compass

is senior editor for Morningstar Australia

© 2022 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This information is to be used for personal, non-commercial purposes only. No reproduction is permitted without the prior written consent of Morningstar. Any general advice or 'regulated financial advice' under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), or its Authorised Representatives, and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information, refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ). Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Morningstar’s full research reports are the source of any Morningstar Ratings and are available from Morningstar or your adviser. Past performance does not necessarily indicate a financial product's future performance. To obtain advice tailored to your situation, contact a licensed financial adviser. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782. The article is current as at date of publication.

Email To Friend